APT(SH:688617) Sou Hu Cai Jing·2025-04-28 12:30Company Overview - Shenzhen Huatai Medical Devices Co., Ltd. specializes in the research, production, and sales of electrophysiological and interventional medical devices [1] - The main products include electrophysiological devices, coronary access devices, peripheral vascular interventional devices, and non-vascular interventional medical devices [1] Financial Performance - For Q1 2025, the company reported revenue of 564 million yuan, representing a year-on-year increase of 23.93% [1] - The net profit for the same period was 183 million yuan, showing a year-on-year growth of 30.69% [1] - The gross profit margin stood at 73.09% [1] Market Position - As of the latest data, Huatai Medical's stock closed at 427.1 yuan, down 1.38%, with a rolling price-to-earnings (PE) ratio of 57.90 times [1] - The company's total market capitalization is 41.464 billion yuan [1] - In comparison, the average PE ratio for the medical device industry is 46.40 times, with a median of 34.81 times, placing Huatai Medical at the 95th position in the industry ranking [1][2] Institutional Holdings - As of Q1 2025, a total of 109 institutions hold shares in Huatai Medical, including 106 funds and 3 other entities, with a total shareholding of 47.1568 million shares valued at 18.264 billion yuan [1]